J Korean Orthop Res Soc.  2009 Dec;12(2):94-102.

Drug Therapy for Osteonecrosis of the Femoral Head

Affiliations
  • 1Department of Orthopaedic Surgery, Seoul National University College of Medicine, Seoul, Korea. oskim@snu.ac.kr

Abstract

Total hip replacement arthroplasty is performed in many cases of osteonecrosiss of the femoral head(ONFH). However, there are still problems associated with postoperative functional limitation and revision arthroplasty due to wear of implants because ONFH usually occurs at relatively young adults. Therefore, the efforts to promote regeneration of ONFH or to delay progression of the disease should be required. Recently, the use of pharmacological agents for the treatment of ONFH has been introduced based on several hypotheses of pathophysiology or risk factors for ONFH. We describe theoretical rationale and short-term clinical results of pharmacological treatments for ONFH.


MeSH Terms

Arthroplasty
Arthroplasty, Replacement, Hip
Head
Humans
Osteonecrosis
Regeneration
Risk Factors
Young Adult
Full Text Links
  • JKORS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr